Urinary incontinence is a common, though often hidden, medical problem among the elderly. Urinary continence requires integrity of the neural, muscular, and hormonal systems. Five distinct types of urinary incontinence can be distinguished based on patient symptoms. A variety of factors can impair continence, including aging, environmental barriers, and medications. Both pharmacological and nonpharmacological measures are useful in the treatment of incontinence.
Get full access to this article
View all access options for this article.
References
1.
MohideEA. The prevalence and scope of urinary incontinence. In: OuslanderJG, ed. Clinics in geriatric medicine: Urinary incontinence. Philadelphia: WB Saunders, 1986.
2.
FarleyD. Incontinence comes out of the closet. FDA Consumer1987; 52: 5–9.
3.
OuslanderJGKaneRLAbrassIB. Urinary incontinence in elderly nursing home patients. JAMA1982; 248: 1194–8.
4.
WellsTJ. Social and psychological implications of incontinence. In: BrocklehurstJC, ed. Urology in the elderly. New York: Churchill Livingstone, 1984: 107–26.
5.
NoelklerLS. Incontinence in elderly cared for by family. Gerontologist1987; 27: 194–200.
6.
DioknoACBrockBMBrownMB. Prevalence of urinary incontinence and other urologic symptoms in the noninstitutionalized elderly. J Urol1986; 136: 1022–5.
7.
WolinL. Stress incontinence in young healthy nulliparous female subjects. J Urol1969; 101: 545–9.
8.
MittenessLS. The management of urinary incontinence by community living elderly. Gerontologist1987; 27: 185–93.
9.
YarnellJVogelGRichardsCStephensonT. The prevalence and severity of urinary incontinence in women. J Epidemiol Community Health1981; 35: 71–4.
10.
VetterNJonesDVictorC. Urinary incontinence in the elderly at home. Lancet1981; 2: 1275–7.
11.
NortonC. The effects of urinary incontinence in women. Inst Rehabil Med1982; 4: 9–14.
12.
DioknoAC. Practical approach to the management of urinary incontinence in the elderly. Compr Ther1983; 9 (7): 67–75.
WilliamsMEPannillFC. Urinary incontinence in the elderly. Ann Intern Med1982; 97: 895–907.
19.
OuslanderJG. Urinary incontinence in the elderly. West J Med1981; 135: 482–91.
20.
International Continence Society. First report on the standardization of terminology of lower urinary tract function. Br J Urol1976; 48: 39–42.
21.
OuslanderJKaneRVollmerSMenezesM. Technologies for managing urinary incontinence (health technology case study 33). OTA-HCS-3. Washington, D.C.: U.S. Congress, Office of Technology Assessment, July 1985.
22.
WellsTJBrinkCADioknoAC. Urinary incontinence in elderly women: Clinical findings. J Am Geriatr Soc1987; 35: 933–9.
23.
BrinkC. Assessing the problem. Geriatr Nurs1981; 1: 241–5.
24.
BeislandHOFossbergESanderS. Urethral sphincter insufficiency in postmenopausal females: Treatment with phenylpropanolamine and estriol separately and in combination. Urol Int1984; 39: 211–6.
25.
McEvoyGKMcquarrieGM, eds. American hospital formulary service drug information 88. Bethesda, MD: American Society of Hospital Pharmacists, 1988.
26.
United States Pharmacopeial Convention. USP-DIVol. 1: Drug information for the health care provider. 8th ed.Rockville, MD: U.S. Pharmacopeial Convention, 1988.
27.
Physicians' Desk Reference. 39th ed.Oradell, NJ: Medical Economics, 1985.
28.
AmbrosiniPJNurnbergHG. Enuresis and incontinence occurring with neuroleptics. Am J Psychol1980; 137: 1278–9.
29.
KirkulataGH. Urinary incontinence secondary to drugs. Urology1983; 22: 88–90.
30.
KirkulataGHMercerARWinsorGM. Prazosin as a cause of urinary incontinence. Urology1981; 18: 618–9.
31.
BissadaNKFinkbeinerAE. Lower urinary tract function and dysfunction. Pharmacologic treatment of lower urinary tract disorders. New York: Appleton-Century-Crofts, 1978: 93–151.
32.
WillingtonFL. Urinary incontinence and the significance of nocturia and frequency. In: CapeRDCoeRMRossmanI, eds. Fundamentals of geriatric medicine. New York: Raven Press, 1983: 117–28.
33.
CaineM. Bromocriptine and urinary incontinence (letter). Lancet1984; 1: 228.
34.
KhannaOP. Disorders of micturition. Neuropharmacologic basis and results of drug therapy. Urology1976; 8: 316–27.
35.
KumarBB. Urinary incontinence associated with metoclopramide (letter). JAMA1984; 251: 1553.
36.
SandykKR. Urinary incontinence associated with clonazepam therapy (letter). S Afr Med J1983; 64: 230.
37.
ResnickNMYallaSV. Management of urinary incontinence in the elderly. N Engl J Med1985; 313: 800–5.
VorstmanBLockhartJKaufmanMPolitanoV. Polytetrafluoroethylene injection for urinary incontinence in children. J Urol1985; 133: 248–50.
41.
American Medical Association Department of Drugs. AMA drug evaluations. 3rd ed.Littleton, MA: Publishing Sciences Group, 1977.
42.
BradleyDVCazortRJ. Relief of bladder spasm by flavoxate; a comparative study. J Clin Pharmacol1970; 10: 65–8.
43.
ThompsonIMLauvetzR. Oxybutynin in bladder spasm and enuresis. Urology1976; 8: 452–4.
44.
BaryPRMoiseyCVStephensonTP. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride. In: ZinnerNRSterlingAM, eds. Female incontinence. New York: Alan R. Liss, 1981.
45.
MeyhoffHHGerstenbergTCNordlingJ. Placebo—the drug choice in female motor urge incontinence?Br J Urol1983; 55: 34–7.
46.
CastledenCMGeorgeCFRenwickAGAsherMJ. Imipramine: A possible alternative for urinary incontinence in the elderly. J Urol1981; 125: 318–20.
47.
WalterSMeyhoffHHGerstenbergTC. Urinary incontinence in the female. Acta Obstet Gynecol Scand1984; 63: 159–61.
48.
RobinsonJMBrocklehurstJC. Emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence associated with detrusor instability in elderly women. Br J Urol1983; 55: 371–6.
49.
BrocklehurstJC. Drug effects in urinary incontinence, urology in the elderly. New York: Churchill Livingstone, 1984.
50.
AwadSADownieJW. Pharmacologic therapy. In: McGuireEJ, ed. Urinary incontinence. New York: Grune and Stratton, 1981.
51.
JenikeMA. Handbook of geriatric psychopharmacology. Littleton, MA: PSG Publishing, 1985.
52.
WebsterGD. Advances in treating lower urinary tract dysfunction. Drug Ther1982; 13: 113–35.
53.
CastledenCMDuffinHMGulatiRS. Double-blind study of imipramine and placebo for incontinence due to bladder instability. Age Ageing1986; 15: 299–303.
54.
PalmerJ. Report of a double-blind crossover study of flurbiprofen and placebo in detrusor instability. J Int Med Res1983; 11 (suppl 2): 11–7.
55.
CardozoLDStantonSL. A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. J Urol1980; 123: 399–401.
56.
CardozoLDStantonSLRobinsonH. Evaluation of flurbiprofen in detrusor instability. Br Med J1980; 2: 281–2.
57.
FormanAAnderssonKEHendrikssonLRudTUlmstenU. Effects of nifedipine on the smooth muscle of the human urinary tract in vitro and in vivo. Acta Pharmacol Toxicol1978; 43: 111–8.
58.
PalmerJHWorthPHLExton-SmithAN. Flunarizine: A once-daily therapy for urinary incontinence. Lancet1981; 2: 279–81.
59.
KlarskovPGerstenbergTCHaldT. Bladder training and terodiline in females with idiopathic urge incontinence and stable detrusor function. Scand J Nephrol1986; 20: 41–6.
60.
PETERS D and the Multicentre Study Group. Terodiline in the treatment of urinary frequency and motor urge incontinence. Scand J Nephrol1984; 87 (suppl): 21–34.
61.
FISCHER-RASMUSSEN W and the Multicentre Study Group. Evaluation of long term safety and clinical benefit of terodiline in women with urgency/urge incontinence. Scand J Nephrol1984; 87 (suppl): 35–47.
62.
GerstenbergTCKlarskovPRamirezDHaldT. Terodiline in the treatment of women with urgency and motor urge incontinence. Br J Urol1986; 58: 129–33.
63.
McFarlaneJRTolleyDA. The effect of terodiline on patients with detrusor instability. Scand J Nephrol1984; 87 (suppl): 51–4.
64.
NorlenLSundinTWaagsteinF. Beta-adrenoceptor stimulation of the human urinary bladder in vivo. Acta Pharmacol Toxicol1978; 43 (11): 26–30.
65.
LindholmPLoseG. Terbutaline in the treatment of female urge incontinence. Urol Int1986; 41: 158–60.
66.
DioknoACTaubM. Ephedrine in the treatment of urinary incontinence. Urology1975; 5: 624–5.
67.
FossbergEBeislandHOLundgrenRA. Stress incontinence in females: Treatment with phenylpropanolamine. Urol Int1983; 38: 293–9.
68.
LehtonenTRannikkoSLindellO. The effect of phenylpropanolamine on female stress urinary incontinence. Ann Chir Gynaecol1986; 75: 236–41.
69.
HiltonPStantonSL. The use of intravaginal estrogen cream in genuine stress incontinence. Br J Obstet Gynaecol1983; 90: 940–4.
70.
CaineMRazS. The role of female hormones in stress incontinence. Proceedings of the 16th Congress of the International Society of Urologists. Amsterdam: International Society of Urologists, 1973.
71.
SmithP. Postmenopausal urinary symptoms and hormone replacement therapy (letter). Br Med J1976; 2: 941.
72.
SmithP. Age changes in the female urethra. Br J Urol1972; 44: 667–76.
73.
FaberPHeidenrichJ. Treatment of stress incontinence with estrogen in postmenopausal women. Urol Int1977; 32: 221–3.
74.
WalterSWolfHBarbeloHJensenHK. Urinary incontinence in post-menopausal women treated with estrogens; a double-blind clinical trial. Urol Int1978; 33: 135–43.
75.
WhiteheadMMinaldiJKitchenYSharplesMJ. Systemic absorption of estrogen from premarin vaginal cream. In: CookID, ed. The role of estrogen and progesterone in the management of menopause. Lancaster, England: MTP Press, 1978.
76.
SchreiterFFuchsPStockampK. Estrogenic sensitivity of α-receptors in the urethra musculature. Urol Int1976; 31: 13–9.
77.
WeinAJMalloyTRShaferFRaezerDM. The effects of bethanechol chloride on urodynamic parameters in normal women and in women with significant residual urine volumes. J Urol1980; 124: 397–9.
78.
LightJKScottFB. Bethanechol chloride and the traumatic cord bladder. J Urol1982; 128: 85–7.
79.
AnderssonKEHedlundAEHMattiassonA. Effects of prazosin on isolated human urethra and in patients with lower motor neuron lesions. Invest Urol1981; 19: 39–42.
